Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD
NCT05192122
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
OTHER:
Discontinue maintenance therapy SOC
Sponsor
University of Illinois at Chicago